Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.250
+0.003 (1.05%)
At close: Dec 20, 2024, 4:00 PM
0.257
+0.006 (2.56%)
After-hours: Dec 20, 2024, 6:58 PM EST
Eterna Therapeutics Employees
Eterna Therapeutics had 8 employees as of December 31, 2023. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
$74,750
Profits / Employee
-$5,618,625
Market Cap
12.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marinus Pharmaceuticals | 166 |
| Cosmos Health | 123 |
| Lifeward | 108 |
| Ekso Bionics Holdings | 72 |
| Aspira Women's Health | 64 |
| Brainstorm Cell Therapeutics | 29 |
ERNA News
- 5 weeks ago - Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing - GlobeNewsWire
- 7 weeks ago - Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success - GlobeNewsWire
- 2 months ago - Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases - GlobeNewsWire
- 8 months ago - Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs - GlobeNewsWire
- 8 months ago - Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board - GlobeNewsWire
- 10 months ago - Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors - GlobeNewsWire
- 1 year ago - Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) - GlobeNewsWire
- 1 year ago - Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer - GlobeNewsWire